Orion Pharma Ltd and Orion Infusion Ltd – two companies of Orion Group – have recommended a 10% cash dividend each for their shareholders for the financial year ended on 30 June 2020.
The dividends were recommended at the companies' board meetings on Sunday evening.
The approval of the dividend of Orion Pharma will be finalised at its 55th annual general meeting (AGM) and that of Orion Infusion will be finalised at its 37th AGM.
Both the AGMs are slated for 23 December this year and the record date for both is 29 November.
According to the price-sensitive information released by the companies, Orion Pharma reported a consolidated earnings per share (EPS) of Tk2.84 as of June 2020 and Orion Infusion reported an EPS of Tk1.46.
The consolidated net asset value (NAV) per share including revaluation surplus of Orion Pharma stood at Tk76.77 for the 2019-20 financial year. The NAV per share of Orion Infusion stood at Tk12.66.